Today is the last day of one of the world´s most important pharma events – DCATWeek in New York City!

Our Tiefenbacher Group team sends greetings and their impressions of DCAT Week from the Big Apple! These were very successful days for Tiefenbacher Group. During these days we presented our latest product portfolio and innovations to our existing and potential new partners at the DCAT Week in New York City. We love the inspiring atmosphere here and look forward to exciting encounters and interesting discussions on this final day.

DCAT Week is the premier global event held annually in New York City, USA. Especially for companies engaged in the Bio/Pharmaceutical Manufacturing Value Chain this event is important. Generally it is hosted by the Drug, Chemical & Associated Technologies Association (DCAT). Emphasising that it is a not-for-profit, member-supported, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies.

Tiefenbacher Pharmaceuticals, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).

For more information about our finished dosage forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: or visit us on: